Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma. Scandurra D, Meijer TWH, Free J, van den Hoek JGM, et al. Radiother Oncol 2022 Feb 5. pii: S0167-8140(22)00080.

Read + Share

Amedeo Smart

Independent Medical Education

Scandurra D, Meijer TWH, Free J, van den Hoek JGM, et al. Evaluation of robustly optimised intensity modulated proton therapy for nasopharyngeal carcinoma. Radiother Oncol 2022 Feb 5. pii: S0167-8140(22)00080.
PMID: 35134448